Morgan Stanley Q4 2025 Earnings: Investment Banking Is Back, but Is the Stock Fully Priced?

Morgan Stanley’s Q4 2025 earnings surpassed expectations, driven by investment banking recovery and stable wealth management. The firm achieved record profits, with an estimated fair value of $180 per share, indicating limited upside post-rally. Despite strengths in diversified revenue, the stock appears fairly valued against market risks and economic conditions.

TL;DR Summary

  • Morgan Stanley (MS:NYSE) delivered a strong Q4 2025, driven by a sharp rebound in investment banking and steady wealth management growth.
  • Full-year profitability and returns remain well above cost of capital, reinforcing MS as a high-quality franchise.
  • However, after a post-earnings rally, the stock looks close to fair value rather than clearly cheap.
  • Fair value estimate: around $180 per share, implying limited upside at current levels unless the deal cycle stays strong.

Quarter Recap

Morgan Stanley reported Q4 2025 results that clearly exceeded market expectations. Net revenues rose meaningfully year-over-year, with earnings boosted by a recovery in advisory and underwriting activity. Wealth Management continued to provide a stable backbone, while Institutional Securities re-accelerated as capital markets activity improved into year-end.

The earnings release confirmed that FY2025 was a record year for the firm in terms of revenues and earnings, validating the long-term strategy of building a more balanced, fee-driven business alongside cyclical market activities.


Key Highlights

  • Q4 net revenues: $17.9B, up solidly year-over-year
  • Q4 EPS: $2.68
  • FY2025 EPS: $10.21 (record)
  • ROTCE: ~22%, firmly above historical averages
  • CET1 capital ratio: ~15%, supporting dividends and buybacks
  • Wealth Management revenues: $8.4B in Q4, reflecting durable fee income
  • Investment Banking revenues: sharply higher year-over-year, signaling a deal-cycle rebound

SWOT Analysis

Morgan Stanley’s Q4 results highlight the strength of its integrated model: a resilient wealth management base combined with cyclical upside from investment banking. The following SWOT translates these drivers into estimated valuation impacts.

Strengths

  • High-quality earnings power and profitability driven by diversified businesses and ~22% ROTCE. (Estimated impact: +6% to +12%)
  • Wealth Management scale and stickiness, with large fee-based assets providing earnings stability. (+5% to +10%)
  • Clear rebound in investment banking, supporting upside to normalized earnings. (+4% to +9%)
  • Strong capital position (CET1 ~15%), enabling consistent capital returns. (+2% to +5%)

Weakness

  • Earnings remain market-sensitive, particularly in trading and underwriting. (−2% to −6%)
  • Rising technology and execution costs, which could pressure margins if they become structural. (−2% to −5%)
  • Isolated credit noise, including CRE-related charge-offs, reminds investors of tail risks. (−1% to −3%)

Opportunities

  • Sustained deal-cycle recovery could keep Institutional Securities returns elevated. (+4% to +10%)
  • Further shift toward fee-based wealth revenues enhances durability and valuation quality. (+3% to +8%)
  • Operating leverage, as incremental revenues flow through at higher margins. (+2% to +6%)

Threats

  • A reversal in capital markets sentiment could quickly compress revenues and multiples. (−6% to −15%)
  • Regulatory or capital rule changes that reduce returns on equity. (−3% to −8%)
  • Cost inflation becoming structural, limiting valuation re-rating. (−2% to −7%)
SWOT price impact chart for Morgan Stanley Q4 2025, illustrating strengths, weaknesses, opportunities, and threats with estimated share price impact ranges from −20% to +15%.
Morgan Stanley Q4 2025 SWOT analysis showing estimated price impact ranges. Strengths and opportunities reflect investment banking recovery and wealth management durability, while weaknesses and threats capture market cyclicality and downside risks.

Valuation Scenarios

For Morgan Stanley, valuation is best anchored on tangible book value and returns on equity. With tangible book value per share around $50, different P/TBV multiples reflect how much premium the market assigns to a ~20%+ ROTCE franchise.

Bear case (~$160)

  • Deal activity cools and market conditions soften.
  • Valuation compresses toward a more conservative quality-bank multiple.

Base case (~$180)

  • Wealth Management remains stable and investment banking normalizes.
  • MS sustains premium returns without further multiple expansion.

Bull case (~$200)

  • Deal momentum persists and the integrated-firm narrative strengthens.
    • Market assigns a top-tier multiple to durable earnings power.

Probability-weighted fair value: ~$180 per share.

Valuation scenarios chart for Morgan Stanley Q4 2025 with three bars showing bear case at $160, base case at $180, and bull case at $200, alongside a dotted fair value line at $180.
Morgan Stanley Q4 2025 valuation scenarios showing bear, base, and bull price targets. The probability-weighted fair value centers around $180 per share, highlighting limited upside after the post-earnings rally.

Verdict

Morgan Stanley remains a best-in-class financial franchise, and Q4 2025 confirms that its diversified model works when markets recover. However, after the post-earnings rally, the stock appears fairly valued rather than obviously undervalued.

For long-term, value-oriented investors:

  • Above ~$190: upside looks limited unless the deal cycle stays unusually strong.
  • Around ~$180: valuation is reasonable for a high-quality compounder.
  • Below ~$165: the stock would begin to offer a more compelling margin of safety.

Call to Action

If you found this breakdown useful, follow SWOTstock for clear, fundamentals-driven earnings analysis that cuts through the noise and focuses on valuation, risk, and long-term returns.


Disclaimer

This article is for informational purposes only and does not constitute investment advice. All analysis is based on publicly available company disclosures. Investors should conduct their own research or consult a financial professional before making investment decisions.


Goldman Sachs and Morgan Stanley: A High-Stakes Earnings Season for Wall Street’s Finest

Preview the upcoming Q2 2025 earnings for Goldman Sachs and Morgan Stanley. Explore key themes, strategic differences, and what investors should watch as Wall Street’s top banks report.

TL;DR – Two Different Engines, One Market Test

As Goldman Sachs and Morgan Stanley prepare to report their second-quarter results, investors are watching closely to see how two of Wall Street’s most iconic firms are navigating a shifting macro environment. While Morgan Stanley has leaned into wealth management as its long-term growth pillar, Goldman continues to reposition itself after a retreat from consumer banking and a volatile stretch in investment banking. The upcoming earnings will offer a fresh look at which model is winning in 2025—and whether either name is undervalued relative to its forward potential.


Q1 Recap: Strategic Divergence on Full Display

In the first quarter of 2025, the divergence in strategy between these two institutions became increasingly evident. Goldman Sachs delivered better-than-expected results, driven largely by strength in its global markets division—particularly fixed income and commodities trading. While investment banking revenues remained muted, the firm’s Asset and Wealth Management segment showed encouraging growth, quietly contributing to earnings stability amid broader volatility.

Morgan Stanley, in contrast, leaned into its now-dominant wealth management franchise, which continues to anchor its earnings with more predictable, fee-based income. Trading revenues were healthy, though less volatile than Goldman’s, and investment banking activity remained sluggish. The integration of E*TRADE and Eaton Vance appears to be progressing, but margins continue to be scrutinized by analysts who want to see more operating leverage.

Both stocks have tracked broader market gains this year, aided by rising investor sentiment and increased risk appetite. However, the strong run-up in equity markets sets a higher bar for Q2 performance—and makes any shortfall more likely to trigger a valuation reset.


Q2 2025 Preview: Key Themes to Watch

📈 1. Investment Banking Activity and the M&A Pipeline

The long-awaited recovery in deal activity has been uneven, but early signs point to a modest thaw in M&A and equity underwriting markets. Investors will want to see whether either bank is capturing greater wallet share as clients cautiously return to the table. Goldman, with its deep advisory bench, may be positioned to benefit from any early rebound.

💼 2. Wealth Management Profitability and Scale

Morgan Stanley’s wealth business, now a cornerstone of its strategy, remains in focus—particularly operating margins and net new assets. Investors will look for signs that scale advantages from prior acquisitions are beginning to deliver incremental earnings leverage. Conversely, any slip in cost discipline or fee compression could raise concerns about future growth.

📊 3. Trading Performance and Market Volatility

With macro volatility subsiding somewhat in Q2, trading desks may face tougher year-over-year comps. Goldman’s exposure to fixed income and commodities could give it an edge in any remaining dislocations. Morgan Stanley’s more balanced exposure may serve it well in calmer markets, but could also limit upside if activity is muted.

🏦 4. Strategic Repositioning at Goldman

Goldman’s exit from its consumer ventures continues to unfold, and the second quarter may offer further updates on its plans to streamline operations and refocus capital. While these efforts have weighed on sentiment in the past, clarity and discipline in execution could turn the narrative more constructive.

💰 5. Capital Return and CET1 Management

Both firms are expected to comment on their capital return strategies following the latest Fed stress test results. Goldman has historically been more aggressive with buybacks, while Morgan Stanley may emphasize stability and capital preservation. Investors will weigh these decisions against current payout ratios and the firms’ risk-weighted asset profiles.


SWOT Analysis: Comparing Strategic Profiles

SWOT analysis table comparing Goldman Sachs and Morgan Stanley ahead of Q2 2025 earnings, highlighting strengths, weaknesses, opportunities, and threats for each firm.

Valuation in Context: Discounted for Uncertainty

From a valuation perspective, both firms trade at a discount to their historical averages, reflecting persistent questions around the pace of recovery in core businesses.

  • Goldman Sachs (GS) is currently trading at approximately 11.2x forward earnings, a discount that arguably reflects both the overhang from its consumer pivot and cyclical risk in trading and advisory.
  • Morgan Stanley (MS) commands a higher multiple, at around 13.3x forward earnings, underpinned by the predictability of its wealth franchise and a more balanced revenue base.

However, if investment banking activity accelerates meaningfully in the second half of the year, Goldman may be poised for a multiple re-rating. Conversely, if market volatility diminishes further, Morgan Stanley’s stable income streams may prove more defensive.


Bottom Line: Different Models, Same Market Test

As both firms head into Q2 earnings, the contrast between Goldman’s capital markets orientation and Morgan Stanley’s wealth-driven stability will once again be on full display. Investors will be looking not only for solid headline numbers, but for forward guidance that supports each firm’s strategic trajectory. Whether it’s Goldman’s return to its core strengths or Morgan Stanley’s steady ascent in fee-based income, the upcoming results could significantly shift investor sentiment—and relative valuations—for the rest of the year.


Stay Ahead of the Curve

📩 Subscribe to SWOTstock.com for full earnings recaps, updated SWOT profiles, and revised valuation scenarios for both Goldman Sachs and Morgan Stanley—posted immediately after earnings are released.


Disclaimer

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Always perform your own due diligence or consult a licensed financial advisor before making investment decisions.


Leave a comment